AJP - Endo  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (July 20, 2004). doi:10.1152/ajpendo.00240.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/1/E37    most recent
00240.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raj, D. S.
Right arrow Articles by Ferrando, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raj, D. S.
Right arrow Articles by Ferrando, A.
Submitted on June 7, 2004
Accepted on July 12, 2004

GLUTAMINE KINETICS AND PROTEIN TURNOVER IN END-STAGE RENAL DISEASE

Dominic SC Raj1*, Tomas Welbourne2, Elizabeth A Dominic3, Debra Waters4, Robert Wolfe5, and Arny Ferrando5

1 Division of Nephrology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
2 Department of Physiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA
3 Albuquerque Academy, Albuquerque, NM, USA
4 Division of Epidemiology and Preventive Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
5 Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA

* To whom correspondence should be addressed. E-mail: draj{at}salud.unm.edu.

Alanine and glutamine constitute the two most important nitrogen carriers released from the muscle. We studied the intracellular amino acid transport kinetics and protein turnover in nine end-stage renal disease (ESRD) patients and eight controls using stable isotopes of phenylalanine, alanine and glutamine. The amino acid transport kinetics and protein turnover were calculated with a 3-pool model from the amino acid concentrations and enrichment in the artery, vein and muscle compartments. Muscle protein breakdown was more than synthesis (nmol/min-1.100 ml leg-1) during hemodialysis (HD) (169.8±20.0 vs. 125.9±21.8, p<0.05) and in controls (126.9±6.9 vs. 98.4±7.5, p<0.05), but synthesis and catabolism were comparable pre-HD (100.7±15.7 vs. 103.4±14.8). The whole body protein catabolism decreased by 15% during HD. The intracellular appearance of alanine (399.0±47.1 vs. 243.0±34.689) and glutamine (369.7±40.6 vs. 235.6±27.5) from muscle protein breakdown increased during dialysis (nmol/min-1.100 ml leg-1,p<0.01). However, the de novo synthesis of alanine (3468.9 ±572.2 vs. 3140.5±467.7) and glutamine (1751.4±82.6 vs. 1782.2±86.4) did not change significantly intra-dialysis (nmol/min-1.100 ml leg-1). Branched chain amino acid catabolism (191.8±63.4 vs. -59.1±42.9) and non-protein glutamate disposal (347.0±46.3 vs. 222.3±43.6) increased intra-dialysis compared to pre-HD (nmol/min-1.100 ml leg-1, p<0.01). The mRNA levels of glutamine synthase (1.45±0.14 vs. 0.33±0.08, p<0.001) and branched chain keto acid dehydrogenase-E2 (3.86±0.48 vs. 2.14±0.27, p<0.05) in the muscle increased during HD. Thus, intracellular concentrations of alanine and glutamine are maintained during HD by augmented release of the amino acids from muscle protein catabolism. While muscle protein breakdown increased intra-dialysis, the whole body protein catabolism decreased, suggesting central utilization of amino acids released from skeletal muscle.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Reuter, P. Bangen, B. Edemir, U. Hillebrand, H. Pavenstadt, S. Heidenreich, and D. Lang
The HSP72 stress response of monocytes from patients on haemodialysis is impaired
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2838 - 2846.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. C Ligthart-Melis, M. C. van de Poll, P. G Boelens, C. H. Dejong, N. E. Deutz, and P. A. van Leeuwen
Glutamine is an important precursor for de novo synthesis of arginine in humans
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1282 - 1289.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. C. G. van de Poll, G. C. Ligthart-Melis, P. G. Boelens, N. E. P. Deutz, P. A. M. van Leeuwen, and C. H. C. Dejong
Intestinal and hepatic metabolism of glutamine and citrulline in humans
J. Physiol., June 1, 2007; 581(2): 819 - 827.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. S. C. Raj, O. Adeniyi, E. A. Dominic, M. A. Boivin, S. McClelland, A. H. Tzamaloukas, N. Morgan, L. Gonzales, R. Wolfe, and A. Ferrando
Amino acid repletion does not decrease muscle protein catabolism during hemodialysis
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1534 - E1542.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. J. M. Cano, D. Fouque, and X. M. Leverve
Application of Branched-Chain Amino Acids in Human Pathological States: Renal Failure
J. Nutr., January 1, 2006; 136(1): 299S - 307S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.